SMAD4 and Intellectual disability: Gene ontology analysis by IPA software revealed that transcriptional targets of AR, KDM5B, and SMAD4 that were differentially expressed in response to BPA treatment were significantly associated with “autism spectrum disorder or intellectual disability” (Table 2, Additional files 8, 9, 10).